Asset Details
Do you wish to reserve the book?
Diagnosing Periprosthetic Joint Infection: Has the Era of the Biomarker Arrived?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Diagnosing Periprosthetic Joint Infection: Has the Era of the Biomarker Arrived?
Do you wish to request the book?
Diagnosing Periprosthetic Joint Infection: Has the Era of the Biomarker Arrived?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Diagnosing Periprosthetic Joint Infection: Has the Era of the Biomarker Arrived?
2014
Overview
Background
The diagnosis of periprosthetic joint infection (PJI) remains a serious clinical challenge. There is a pressing need for improved diagnostic testing methods; biomarkers offer one potentially promising approach.
Questions/purposes
We evaluated the diagnostic characteristics of 16 promising synovial fluid biomarkers for the diagnosis of PJI.
Methods
Synovial fluid was collected from 95 patients meeting the inclusion criteria of this prospective diagnostic study. All patients were being evaluated for a revision hip or knee arthroplasty, including patients with systemic inflammatory disease and those already receiving antibiotic treatment. The Musculoskeletal Infection Society (MSIS) definition was used to classify 29 PJIs and 66 aseptic joints. Synovial fluid samples were tested by immunoassay for 16 biomarkers optimized for use in synovial fluid. Sensitivity, specificity, and receiver operating characteristic curve analysis were performed to assess for diagnostic performance.
Results
Five biomarkers, including human α-defensin 1-3, neutrophil elastase 2, bactericidal/permeability-increasing protein, neutrophil gelatinase-associated lipocalin, and lactoferrin, correctly predicted the MSIS classification of all patients in this study, with 100% sensitivity and specificity for the diagnosis of PJI. An additional eight biomarkers demonstrated excellent diagnostic strength, with an area under the curve of greater than 0.9.
Conclusions
Synovial fluid biomarkers exhibit a high accuracy in diagnosing PJI, even when including patients with systemic inflammatory disease and those receiving antibiotic treatment. Considering that these biomarkers match the results of the more complex MSIS definition of PJI, we believe that synovial fluid biomarkers can be a valuable addition to the methods utilized for the diagnosis of infection.
Level of Evidence
Level II, diagnostic study. See Instructions for Authors for a complete description of levels of evidence.
Publisher
Springer US,Lippincott Williams & Wilkins Ovid Technologies
Subject
Acute-Phase Proteins - analysis
/ Adult
/ Aged
/ Antimicrobial Cationic Peptides - analysis
/ Arthritis, Infectious - diagnosis
/ Arthritis, Infectious - microbiology
/ Arthroplasty, Replacement, Hip - adverse effects
/ Arthroplasty, Replacement, Knee - adverse effects
/ C-Reactive Protein - analysis
/ Female
/ Granulocyte Colony-Stimulating Factor - analysis
/ Hip Prosthesis - adverse effects
/ Humans
/ Interleukin-1alpha - analysis
/ Joint Instability - etiology
/ Knee Prosthesis - adverse effects
/ Leukocyte Elastase - analysis
/ Male
/ Medicine
/ Prosthesis-Related Infections - diagnosis
/ Prosthesis-Related Infections - etiology
/ Proto-Oncogene Proteins - analysis
/ Sports
/ Surgery
